Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 7, 644 (2001)
doi:10.1038/88980
Olivieri to testify against Apotex in Europe
Laura Bonetta1
- Bethesda
Almost five years after it began, Nancy Olivieri's dispute with the Canadian drug manufacturer Apotex over the effects of its drug for thalassemia (deferiprone), and with the University of Toronto (UT) for its role in the affair, shows no signs of abating.Olivieri, Brenda Gallie, John Dick, Peter Durie and Hellen Chan are filing grievances against the University for harassment and infringement on their academic freedom.
To read this story in full you will need to login or make a payment (see right).
